Equibles does not estimate personal net worth.
Get an email with a short summary when Rocket Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get RCKT alertsRocket Pharmaceuticals, Inc. reported in an 8-K filed April 7, 2025 that Sarbani Chaudhuri was appointed Chief Commercial & Medical Affairs Officer, effective April 7, 2025. Sarbani Chaudhuri has spoken on 1 investor event across 1 company, most recently for Rocket Pharmaceuticals, Inc. on March 27, 2026. Rocket Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rocket Pharmaceuticals, Inc. includes Gaurav Shah (CEO and Board Member), Aaron Ondrey (CFO), Carlos Garcia-Parada (CFO) and 7 others.
“On April 7, 2025, Sarbani Chaudhuri was appointed by Rocket Pharmaceuticals, Inc. (the "Company") as the Company's Chief Commercial & Medical Affairs Officer.”
“The approval of Chris Ladi represents an important milestone both for patients and for ROCKET's evolution into a commercial stage organization. Our commercialization approach begins with the patient.”
Proxy statement
Start not stated–present
Last confirmed April 6, 2026
Biotechnology · Healthcare
